Skip to content
Screener

Kura Oncology KURA Gross Profit

Gross Profit at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.26B+7.1%
Amgen logo
AmgenAMGN
$7.24B+17.4%
Exelixis logo
ExelixisEXEL
$608.03M+10.8%
AbbVie logo
AbbVieABBV
$12.7B+14.6%
Incyte logo
IncyteINCY
$1.57B+38.0%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$849.57M+76.7%
Enterprise value$834.76M+99.5%
P/S11.9×+3.3×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

$18.3Mtotal revenue−$262.0Ktotal cost of revenue=$18M

The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →

Filed
May 12, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219481

FAQ

What is Kura Oncology's gross profit?
Kura Oncology (KURA) reported gross profit of $18M in Q1 2026.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Ask your AI about Kura Oncology's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude